Target intelligence / Profile preview

MicroRNA 4711 (MIR4711 (miR-4711))

Target
MIR4711 (miR-4711)
Molecular classification
microRNA (miRNA), Non-coding RNA
01

Overview

MicroRNA 4711 (miR-4711) is a member of the microRNA class—short (20-24 nucleotide) non-coding RNAs involved in post-transcriptional regulation of gene expression by base-pairing to target mRNAs and typically repressing translation or destabilizing the mRNA[1][2]. miR-4711 has been studied particularly in the context of cancer biology, where it regulates cancer stemness and cell cycle progression in colon cancer cells, affecting key oncogenic regulators such as KLF5, MDM2, and TFDP1[1]. Like other microRNAs, miR-4711 is produced by sequential processing of primary transcripts (pri-miRNA) through the action of Drosha and Dicer endonucleases, and incorporated into the RNA-induced silencing complex (RISC) to exert its function[1][2]. MicroRNAs impact various biological processes, including cell proliferation, differentiation, and survival, and their dysregulation is implicated in multiple diseases, particularly cancer[1][2][3][4].

Other names
miR-4711-5phsa-mir-4711MIR4711
02

Mechanism of action

Anti-miRNA oligonucleotides inhibit miRNA function via hybridization and RNase-dependent degradation or sequestration; miRNA mimics restore or enhance target miRNA regulatory activity.

03

Biological functions

Regulation of gene expression (post-transcriptional)Control of mRNA stability and translationRegulation of cell cycleRegulation of cancer stemness
04

Disease associations

Cancer (specifically colon cancer, lung acinar adenocarcinoma)Gene duplication disease
05

Safety considerations

Off-target effects due to miRNA's broad gene regulatory capacityPotential for affecting multiple cell types and biological pathwaysDelivery challenges for miRNA-based therapeutics
06

Interacting drugs

Research medicines such as anti-miRNAs

1 more in the full profile.

07

Biomarkers

MicroRNAs (including miR-4711) as potential diagnostic, prognostic, or predictive biomarkers in cancer

Beyond the preview

Go deeper on MicroRNA 4711 (MIR4711 (miR-4711)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 4711 (MIR4711 (miR-4711)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call